Single-cell mapping identifies MSI+ cells as a common origin for diverse subtypes of pancreatic cancer
Nirakar Rajbhandari(University of California San Diego), Tannishtha Reya(Columbia University Irving Medical Center), Kwun Wah Wen(University of California, San Francisco), Matthew L. McDermott(University of California San Diego), Hannah Pettit(Columbia University Irving Medical Center), Cynthia M Quintero(Columbia University Irving Medical Center), Christian M. Schürch(University Children's Hospital Tübingen), Mari Nakamura(Boston Children's Hospital), Haiyong Han(Translational Genomics Research Institute), Susan Tsai(The Ohio State University Wexner Medical Center), Derek Cridebring(Translational Genomics Research Institute), Emily Diaz(University of California San Diego), Robert J. Wechsler‐Reya(Columbia University Irving Medical Center), L. Paige Ferguson(Cold Spring Harbor Laboratory), Daniel D. Von Hoff(Translational Genomics Research Institute), Andrew M. Lowy(UC San Diego Health System), Michael Goggins(Johns Hopkins University), Jun Wang(South China Agricultural University), Michael Hamilton(University of California San Diego), Marcie Kritzik(University of California San Diego), Nikki K. Lytle(University of California San Diego), Raymond G. Fox(University of California San Diego), Aaron M. Newman(California Institute for Regenerative Medicine)
Cited by 19
Related Papers
Stem cells, cancer, and cancer stem cells
|Nature|2001|9.7k
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
|New England Journal of Medicine|2013|6.6k
The Immune Landscape of Cancer
|Immunity|2018|6.3k
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
|Journal of Clinical Oncology|1997|5.9k
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k